Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.
Identifieur interne : 001349 ( Main/Corpus ); précédent : 001348; suivant : 001350Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.
Auteurs : Yunbao Pan ; Xinran Li ; Gui Yang ; Junli Fan ; Yueting Tang ; Xiaoyue Hong ; Shuang Guo ; Jin Li ; Dongai Yao ; Zhenshun Cheng ; Yufeng Yuan ; Yirong Li ; Xinghuan WangSource :
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [ 1469-0691 ] ; 2020.
Abstract
OBJECTIVES
The outbreak of 2019 coronavirus disease (COVID-19) pandemic in Wuhan, China, has subsided after a hard hit by the disease and subsequent city lockdown. Information on the number of people involved in Wuhan is still inadequate. This study aimed to describe the screening results of 61,437 community members in Wuchang District, Wuhan.
METHODS
In mid-May 2020, Wuhan launched a population-scale city-wide SARS-CoV-2 testing campaign, which aimed to perform nucleic acid and viral antibody testing for citizens in Wuhan. Here we show the screening results of cluster sampled 61,437 residents in Wuchang District, Wuhan, China.
RESULTS
A total of 1470 (2.39%, 95% CI: 2.27-2.52) individuals were detected positive for at least one antiviral antibody. Among the positive individuals, 324 (0.53%, 95% CI: 0.47-0.59) and 1200 (1.95%, 95% CI: 1.85-2.07) were positive for immunoglobulin IgM and IgG, respectively, and 54 (0.08%, 95% CI: 0.07-0.12) were positive for both antibodies. The positive rate of female carriers of antibodies were higher than those of male counterparts (male-to-female ratio of 0.75), especially in elderly citizens (ratio of 0.18 in 90+ age subgroup), indicating a sexual discrepancy in seroprevalence. In addition, viral nucleic acid detection using real-time PCR had showed 8 (0.013%, 95% CI: 0.006-0.026) asymptomatic virus carriers.
CONCLUSIONS
The seroprevalence of SARS-CoV-2 in Wuhan was low. Most of Wuhan residents are still susceptible to this virus. Precautions, such as wearing mask, frequent hand hygiene, and proper social distance, are necessary before an effective vaccine or antiviral treatments are available.
DOI: 10.1016/j.cmi.2020.09.044
PubMed: 33035672
PubMed Central: PMC7539137
Links to Exploration step
pubmed:33035672Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.</title><author><name sortKey="Pan, Yunbao" sort="Pan, Yunbao" uniqKey="Pan Y" first="Yunbao" last="Pan">Yunbao Pan</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Li, Xinran" sort="Li, Xinran" uniqKey="Li X" first="Xinran" last="Li">Xinran Li</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yang, Gui" sort="Yang, Gui" uniqKey="Yang G" first="Gui" last="Yang">Gui Yang</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Fan, Junli" sort="Fan, Junli" uniqKey="Fan J" first="Junli" last="Fan">Junli Fan</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Tang, Yueting" sort="Tang, Yueting" uniqKey="Tang Y" first="Yueting" last="Tang">Yueting Tang</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Hong, Xiaoyue" sort="Hong, Xiaoyue" uniqKey="Hong X" first="Xiaoyue" last="Hong">Xiaoyue Hong</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Guo, Shuang" sort="Guo, Shuang" uniqKey="Guo S" first="Shuang" last="Guo">Shuang Guo</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Li, Jin" sort="Li, Jin" uniqKey="Li J" first="Jin" last="Li">Jin Li</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yao, Dongai" sort="Yao, Dongai" uniqKey="Yao D" first="Dongai" last="Yao">Dongai Yao</name><affiliation><nlm:affiliation>Physical examination center, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Cheng, Zhenshun" sort="Cheng, Zhenshun" uniqKey="Cheng Z" first="Zhenshun" last="Cheng">Zhenshun Cheng</name><affiliation><nlm:affiliation>Department of Pulmonary Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yuan, Yufeng" sort="Yuan, Yufeng" uniqKey="Yuan Y" first="Yufeng" last="Yuan">Yufeng Yuan</name><affiliation><nlm:affiliation>Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China. Electronic address: 1528095049@qq.com.</nlm:affiliation></affiliation></author><author><name sortKey="Li, Yirong" sort="Li, Yirong" uniqKey="Li Y" first="Yirong" last="Li">Yirong Li</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China. Electronic address: 93419136@qq.com.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Xinghuan" sort="Wang, Xinghuan" uniqKey="Wang X" first="Xinghuan" last="Wang">Xinghuan Wang</name><affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: wangxinghuan@whu.edu.cn.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:33035672</idno><idno type="pmid">33035672</idno><idno type="doi">10.1016/j.cmi.2020.09.044</idno><idno type="pmc">PMC7539137</idno><idno type="wicri:Area/Main/Corpus">001349</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001349</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.</title><author><name sortKey="Pan, Yunbao" sort="Pan, Yunbao" uniqKey="Pan Y" first="Yunbao" last="Pan">Yunbao Pan</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Li, Xinran" sort="Li, Xinran" uniqKey="Li X" first="Xinran" last="Li">Xinran Li</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yang, Gui" sort="Yang, Gui" uniqKey="Yang G" first="Gui" last="Yang">Gui Yang</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Fan, Junli" sort="Fan, Junli" uniqKey="Fan J" first="Junli" last="Fan">Junli Fan</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Tang, Yueting" sort="Tang, Yueting" uniqKey="Tang Y" first="Yueting" last="Tang">Yueting Tang</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Hong, Xiaoyue" sort="Hong, Xiaoyue" uniqKey="Hong X" first="Xiaoyue" last="Hong">Xiaoyue Hong</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Guo, Shuang" sort="Guo, Shuang" uniqKey="Guo S" first="Shuang" last="Guo">Shuang Guo</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Li, Jin" sort="Li, Jin" uniqKey="Li J" first="Jin" last="Li">Jin Li</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yao, Dongai" sort="Yao, Dongai" uniqKey="Yao D" first="Dongai" last="Yao">Dongai Yao</name><affiliation><nlm:affiliation>Physical examination center, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Cheng, Zhenshun" sort="Cheng, Zhenshun" uniqKey="Cheng Z" first="Zhenshun" last="Cheng">Zhenshun Cheng</name><affiliation><nlm:affiliation>Department of Pulmonary Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yuan, Yufeng" sort="Yuan, Yufeng" uniqKey="Yuan Y" first="Yufeng" last="Yuan">Yufeng Yuan</name><affiliation><nlm:affiliation>Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China. Electronic address: 1528095049@qq.com.</nlm:affiliation></affiliation></author><author><name sortKey="Li, Yirong" sort="Li, Yirong" uniqKey="Li Y" first="Yirong" last="Li">Yirong Li</name><affiliation><nlm:affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China. Electronic address: 93419136@qq.com.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Xinghuan" sort="Wang, Xinghuan" uniqKey="Wang X" first="Xinghuan" last="Wang">Xinghuan Wang</name><affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: wangxinghuan@whu.edu.cn.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title><idno type="eISSN">1469-0691</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVES</b></p><p>The outbreak of 2019 coronavirus disease (COVID-19) pandemic in Wuhan, China, has subsided after a hard hit by the disease and subsequent city lockdown. Information on the number of people involved in Wuhan is still inadequate. This study aimed to describe the screening results of 61,437 community members in Wuchang District, Wuhan.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>In mid-May 2020, Wuhan launched a population-scale city-wide SARS-CoV-2 testing campaign, which aimed to perform nucleic acid and viral antibody testing for citizens in Wuhan. Here we show the screening results of cluster sampled 61,437 residents in Wuchang District, Wuhan, China.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>A total of 1470 (2.39%, 95% CI: 2.27-2.52) individuals were detected positive for at least one antiviral antibody. Among the positive individuals, 324 (0.53%, 95% CI: 0.47-0.59) and 1200 (1.95%, 95% CI: 1.85-2.07) were positive for immunoglobulin IgM and IgG, respectively, and 54 (0.08%, 95% CI: 0.07-0.12) were positive for both antibodies. The positive rate of female carriers of antibodies were higher than those of male counterparts (male-to-female ratio of 0.75), especially in elderly citizens (ratio of 0.18 in 90+ age subgroup), indicating a sexual discrepancy in seroprevalence. In addition, viral nucleic acid detection using real-time PCR had showed 8 (0.013%, 95% CI: 0.006-0.026) asymptomatic virus carriers.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>The seroprevalence of SARS-CoV-2 in Wuhan was low. Most of Wuhan residents are still susceptible to this virus. Precautions, such as wearing mask, frequent hand hygiene, and proper social distance, are necessary before an effective vaccine or antiviral treatments are available.</p></div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33035672</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin Microbiol Infect</ISOAbbreviation></Journal><ArticleTitle>Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1198-743X(20)30598-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmi.2020.09.044</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The outbreak of 2019 coronavirus disease (COVID-19) pandemic in Wuhan, China, has subsided after a hard hit by the disease and subsequent city lockdown. Information on the number of people involved in Wuhan is still inadequate. This study aimed to describe the screening results of 61,437 community members in Wuchang District, Wuhan.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In mid-May 2020, Wuhan launched a population-scale city-wide SARS-CoV-2 testing campaign, which aimed to perform nucleic acid and viral antibody testing for citizens in Wuhan. Here we show the screening results of cluster sampled 61,437 residents in Wuchang District, Wuhan, China.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1470 (2.39%, 95% CI: 2.27-2.52) individuals were detected positive for at least one antiviral antibody. Among the positive individuals, 324 (0.53%, 95% CI: 0.47-0.59) and 1200 (1.95%, 95% CI: 1.85-2.07) were positive for immunoglobulin IgM and IgG, respectively, and 54 (0.08%, 95% CI: 0.07-0.12) were positive for both antibodies. The positive rate of female carriers of antibodies were higher than those of male counterparts (male-to-female ratio of 0.75), especially in elderly citizens (ratio of 0.18 in 90+ age subgroup), indicating a sexual discrepancy in seroprevalence. In addition, viral nucleic acid detection using real-time PCR had showed 8 (0.013%, 95% CI: 0.006-0.026) asymptomatic virus carriers.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The seroprevalence of SARS-CoV-2 in Wuhan was low. Most of Wuhan residents are still susceptible to this virus. Precautions, such as wearing mask, frequent hand hygiene, and proper social distance, are necessary before an effective vaccine or antiviral treatments are available.</AbstractText><CopyrightInformation>Copyright © 2020. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yunbao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xinran</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Gui</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Junli</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yueting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Xiaoyue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Dongai</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Physical examination center, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Zhenshun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yufeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China. Electronic address: 1528095049@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yirong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China. Electronic address: 93419136@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinghuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: wangxinghuan@whu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2019 novel Coronavirus</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">colloidal gold-based immunochromatographic strip</Keyword><Keyword MajorTopicYN="N">immunoglobulin antibody</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>07</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>09</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>09</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>9</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33035672</ArticleId><ArticleId IdType="pii">S1198-743X(20)30598-X</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2020.09.044</ArticleId><ArticleId IdType="pmc">PMC7539137</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation><ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2004 Dec;10(12):1062-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15606632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2020 Aug;26(8):1193-1195</Citation><ArticleIdList><ArticleId IdType="pubmed">32504052</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Apr 27;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32337590</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):1269-1274</Citation><ArticleIdList><ArticleId IdType="pubmed">32515684</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Immunol. 2000 Dec;37(18):1141-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11451419</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1081-1088</Citation><ArticleIdList><ArticleId IdType="pubmed">32301749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Apr;14(4):341-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24631223</ArticleId></ArticleIdList></Reference><Reference><Citation>J Korean Med Sci. 2020 Jul 27;35(29):e269</Citation><ArticleIdList><ArticleId IdType="pubmed">32715672</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 May 1;368(6490):493-497</Citation><ArticleIdList><ArticleId IdType="pubmed">32213647</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Regul Homeost Agents. 2020 Apr 07;34(2):339-343</Citation><ArticleIdList><ArticleId IdType="pubmed">32253888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation><ArticleIdList><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2020 Jul;81(1):e28-e32</Citation><ArticleIdList><ArticleId IdType="pubmed">32283141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001349 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001349 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= LockdownV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:33035672
|texte= Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33035672" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LockdownV1
| This area was generated with Dilib version V0.6.38. |  |